Get 250+ investors tailored to your startup

Invest in your industry and stage
Emails & contact info included
Excel and CSV export
Automatically

Trusted by 3,000+ startups

Top 50 Medical Startup Investors in Ireland

Last updated: Apr 2024 A list of 50 angel investors and VC funds that invest in Medical startups based in Ireland. We rank investors based on the number of investments they made in Medical companies from Ireland. We update this investor list every month.

Top 50 Medical Startup Investors in Ireland

Investor	Medical Ireland investments
Enterprise Ireland	28
Western Development Commission	9
AIB Seed Capital Fund	9
Irrus Investments	7
HBAN Medtech Syndicate	7
Elkstone Capital Partners	7
Atlantic Bridge	6
Act Venture Capital	6
Furthr VC	6
Fountain Healthcare Partners	5
Kernel Capital	5
Business Venture Partners	5
NDRC	4
Seroba Life Sciences	4
Enterprise Equity	3
Medtech Syndicate Nominee	3
SVG Ventures	2
Delta Partners	2
Cantor Fitzgerald	2
Glanzmann Enterprises	2
Boole	2
SVG Ventures	2
Oyster Capital Partners	2
Partisan Management Group	2
EIT Health	2
Life Sciences Fund Amsterdam	2
Ascentifi	2
Chip Hance	2
Norgine Ventures	1
EarlyBird	1
Silicon Valley Bank	1
Nadav Ben-Chanoch	1
Eoghan Quigley	1
DHKN	1
John Purdy	1
Cliff Emmons	1
HBM-MedFocus	1
Moffett Investment Holdings	1
Business Growth Fund	1
Bpifrance	1
Conor Sheahan	1
Keiretsu Forum Northwest	1
European Investment Bank	1
Declan Magee	1
Street Capital	1
EQT life science	1
Venturewave Capital	1
Malin Corporation	1
HealthCap	1
Invest Northern Ireland	1

Find investors that fund startups like yours. Automatically.

Our algorithm will find investors that invest in your industry, stage, and geography.

Investor list

Enterprise Ireland is the government agency responsible for the development and funding of the indigenous business sector. Their mission is to accelerate the development of companies to achieve strong positions in global markets resulting in increased national and regional prosperity. It was founded in 1998 and headquartered in Dublin, Ireland.

Investment focus

Software, Health Care, Information Technology
Funding Round, Seed, Series A
Ireland, United States, United Kingdom

Portfolio highlights

Lative — Lative automates capacity planning, maximizing profitable sales growth & revenue efficiency for high-performance revenue teams.
Cytidel — Cytidel helps security teams reduce breaches, save time, and stay secure. Vulnerability Management and Cyber Risk Management, and Threat Intelligence Specialists
Positive Carbon — Positive Carbon provides an innovative solution for businesses to track, manage, and reduce food waste. With real-time analytics, CO2 calculation, and a comprehensive learning platform, we help you save costs and achieve sustainability goals. Request a demo today to start making a positive environmental impact.

Supporting communities to grow, investing in businesses to scale and planning for the future of the western region.

Investment focus

Health Care, Medical Device, Biotechnology
Seed, Funding Round, Series A
Ireland, United States

Portfolio highlights

FeelTect — Connected health technology for disruptive improvements to wound care
CitySwift — CitySwift is a data-driven scheduling and planning technology for urban bus networks. It uses artificial intelligence and machine learning to predict journey times and passenger demand, making routes more efficient. Schedulers can create optimized timetables that take into account traffic, events, and hundreds of other external factors, ensuringon-time performance and increased passenger satisfaction.CitySwift was established in 2016 and is operating in Galway, Ireland.
Amara Therapeutics — Amara Therapeutics is passionate about empowering women and men to take control of their pelvic health. Amara Therapeutics use evidence based medicine and behavioural interventions supported by Amara Therapeutics platform of technologies to provide safe, convenient and non-invasive care pathways. At Amara Therapeutics mission is to fix the carepathway for pelvic health patients, connecting healthcare providers, patients and peers through our platform.

The AIB Seed Capital Fund was established in 2007 to provide venture capital for companies at the seed and early stages of development across a range of sectors throughout the Republic of Ireland. The Fund was established under the Enterprise Ireland Seed and Venture Capital Programme 2007-2012.The Fund has a total of â‚¬30m under managementwith AIB and Enterprise Ireland both committing â‚¬15m. It is managed by experienced managers with extensive expertise in making seed and early stage investments, adding value and facilitating business success.The Fund managers are empowered to make seed investments of up to approximately â‚¬500,000. Furthermore, the Fund has the capacity to make investments in later rounds to support the continued growth of investee companies.The Fund will be managed by Enterprise Equity Venture Capital and the Dublin Business Innovation Centre. This unique partnership brings together extensive regional and investment expertise.Enterprise Equity will evaluate and manage all investments outside the city and county of Dublin, as well as investments that require in excess of â‚¬250,000 from the fund within the city and county of Dublin.Dublin Business Innovation Centre (DBIC) will evaluate and manage all investments within the city and county of Dublin when the initial investment amount required from the Fund does not exceed â‚¬250,000.

Investment focus

Software, Health Care, Medical
Seed, Funding Round, Series A
Ireland, United States, Jersey

Portfolio highlights

NewsWhip — The only real-time media monitoring platform that predicts the stories and topics that will matter in the hours ahead.
Offr — Offr is the new way to buy and sell property, quickly and transparently.
Metabolomic Diagnostics — Metabolomic Diagnostics is a deep-tech company specialized in the development of novel biomarker based diagnostic solutions for complex diseases. The company has developed an effective pipeline to firstly identify diagnostic biomarker panels and then translate these panels into clinical assays ready for application in the clinical laboratory.Thispipeline combines the biomarker multiplexing capabilities of Mass Spectrometry, a powerful analytical technology, with the company’s own informatics and statistics solutions to deliver diagnostic innovation. This is reflected in Metabolomic Diagnostics’ strong and versatile IP portfolio of technical innovations and biomarkers.Our VisionMetabolomic Diagnostics’ primary vision is to develop a portfolio of diagnostic solutions which can determine, early in a woman’s pregnancy,her risk of developing major complications much later in her pregnancy and thus enabling personalized care, adapted to each woman’s individual needs. Pregnancy complications like preeclampsia, gestational diabetes, preterm birth, and in-uterine growth restriction, all have the potential to severely impact on the well-being of mother and child.The company’s innovative diagnostic solutions will assist clinicians in re-imagining how these conditions are managed: our novel risk assessment tools are specifically developed in conjunction with prenatal care providers to ensure they make a difference that really matters. This in turn will enable clinicians to improve pregnancy outcomes globally.Our solutions will empower pregnant women: accurate pregnancy risk information will allow a pregnant woman, in partnership with her care provider, to determine what prenatal care is best for her pregnancy.

Irrus Investments is the leading Irish business angel network with international connections. Fueling Irish innovation in medical devices, software, hardware, digital healthcare and life sciences.

Investment focus

Biotechnology, Health Care, Medical Device
Seed, Funding Round, Series A
Ireland, Sweden, United States

Portfolio highlights

FeelTect — Connected health technology for disruptive improvements to wound care
Bluedrop Medical — Evidence shows regular inspection of the feet can greatly reduce the risk of developing a diabetic foot ulcer (DFU).
SymPhysis Medical — SymPhysis Medical's goal is to develop innovative technologies that treat a range of chronic diseases, putting the patient experience at the forefront of our design solutions to improve quality of life.About SymPhysis MedicalSymPhysis Medical's emergent technology, releaze, is a drainage technology to treat a common complication oflate-stage cancers, malignant pleural effusion (MPE). MPE causes signiﬁcant shortness of breath and chest pain in up to 15% of patients with cancer.

HBAN Medtech Syndicate

Investment focus

Medical Device, Medical, Health Care
Seed, Funding Round, Series B
Ireland

Portfolio highlights

FeelTect — Connected health technology for disruptive improvements to wound care
Neurobell — NeuroBell develop novel EEG medical devices for early detection and monitoring of neonatal seizures.
SymPhysis Medical — SymPhysis Medical's goal is to develop innovative technologies that treat a range of chronic diseases, putting the patient experience at the forefront of our design solutions to improve quality of life.About SymPhysis MedicalSymPhysis Medical's emergent technology, releaze, is a drainage technology to treat a common complication oflate-stage cancers, malignant pleural effusion (MPE). MPE causes signiﬁcant shortness of breath and chest pain in up to 15% of patients with cancer.

Elkstone is an investment firm, focusing on entrepreneurs, senior executives, institutional LPs, the venture community, and the Irish diaspora.The objective of the organization is to boost the economic value and overall well-being of the island of Ireland by expanding a network, facilitating deserving investments, and delivering excellentinvestment performance.

Investment focus

Software, Health Care, Medical
Seed, Funding Round, Series A
Ireland, United Kingdom, United States

Portfolio highlights

Lative — Lative automates capacity planning, maximizing profitable sales growth & revenue efficiency for high-performance revenue teams.
Cytidel — Cytidel helps security teams reduce breaches, save time, and stay secure. Vulnerability Management and Cyber Risk Management, and Threat Intelligence Specialists
Kerno — Instantly identify the root cause of any critical issue in your Cloud apps and get back to business in minutes, not hours.

Atlantic Bridge is a Growth Equity Firm with a Cross Border Value Add strategy. We invest in deep technology companies in Europe and the US. Our team is made up of successful entrepreneurs and senior technology industry executives and we invest in strong ambitious entrepreneurs and management teams that have the passion and drive to scale up andexploit major growth opportunities. We help our portfolio companies expand and grow internationally through our global platform with our team and offices in London, Dublin, Munich, Paris and Palo Alto.Atlantic Bridge brings together a unique team of technology entrepreneurs, experienced managers, finance professionals, and investment experts. The team contains a wealth of international business experience across Europe, the UK and the US. They have worked together in various capacities for the last 30 years, bringing a true partnership approach to their firm and their investments. Its investors include the founders, leading institutional investors, and private investors with a track record of investment in successful technology companies.Atlantic Bridge has developed a unique and differentiated strategy that focuses on specific technology themes and the implementation of the “Atlantic Bridge Model” for scaling companies internationally. The “Bridge Model” accelerates the scale-up of technology companies in Europe and the US. This approach is highly differentiated and has delivered strong performance results to date.

Investment focus

Software, Artificial Intelligence, Information Technology
Series A, Series B, Funding Round
United States, Ireland, United Kingdom

Portfolio highlights

Neurobell — NeuroBell develop novel EEG medical devices for early detection and monitoring of neonatal seizures.
LUMA Vision — OneProjects is an Irish-German cardiac imaging specialist.
Cambridge Mechatronics — Cambridge Mechatronics (CML) is a high technology design and engineering company based in Cambridge, UK. We specialise in pioneering and developing cutting-edge mechatronic platform technology from concept to mass production. We achieve this through technology licensing or partnerships with global manufacturing corporations. Our intellectualproperty portfolio consists of over 100 granted patents that we can exploit.

Technology-focused, investing capital and expertise to fuel growth in the most promising ideas and companies. Raised c.€600m across multiple funds and invest from seed to growth.We look for companies with potentially cutting-edge, category-defining businesses in markets including application software, IT infrastructure, communications, Internetand mobile. We help founders create and scale businesses globally. We work as a small team with diverse strengths accessing a community of over 200 founders. The teams and companies we back scale their investor base as they scale their business execution and ambition. We work closely with them in this process. Over the past 25 years have built a broad network of US and European investors and founders that share our vision and approach.Act is based in Dublin, Ireland.Our most recent funds are supported by the European Investment Fund.

Investment focus

Software, Information Technology, Analytics
Funding Round, Seed, Series A
Ireland, United States, United Kingdom

Portfolio highlights

CitySwift — CitySwift is a data-driven scheduling and planning technology for urban bus networks. It uses artificial intelligence and machine learning to predict journey times and passenger demand, making routes more efficient. Schedulers can create optimized timetables that take into account traffic, events, and hundreds of other external factors, ensuringon-time performance and increased passenger satisfaction.CitySwift was established in 2016 and is operating in Galway, Ireland.
GREYSCOUT — Safeguard your reputation and increase revenue with GreyScout, the scalable, always-on platform for fighting IP infringement and grey market sellers.
Spotted Zebra — Spotted Zebra's skills cloud powers skills-based organisations. Our platform ensures skills are the centre of every decision made about people. Whether talent acquisition, talent development or internal mobility, Spotted Zebra focuses people on skills.

Furthr VC invests in transformative tech. Furthr Venture Capital invests in scalable, early-stage companies. We help Ireland's next generation of technology.

Investment focus

Medical, Medical Device, Health Care
Seed, Funding Round, Pre-Seed
Ireland

Portfolio highlights

GREYSCOUT — Safeguard your reputation and increase revenue with GreyScout, the scalable, always-on platform for fighting IP infringement and grey market sellers.
Neurobell — NeuroBell develop novel EEG medical devices for early detection and monitoring of neonatal seizures.
SymPhysis Medical — SymPhysis Medical's goal is to develop innovative technologies that treat a range of chronic diseases, putting the patient experience at the forefront of our design solutions to improve quality of life.About SymPhysis MedicalSymPhysis Medical's emergent technology, releaze, is a drainage technology to treat a common complication oflate-stage cancers, malignant pleural effusion (MPE). MPE causes signiﬁcant shortness of breath and chest pain in up to 15% of patients with cancer.

Fountain Healthcare Partners is an Irish based life science venture capital fund. Fountain is exclusively focused on the life science sector. Specific areas of interest to them are: specialty pharma, medical devices, biotechnology and diagnostics. They will deploy the majority of their capital in Europe with a strong focus on Ireland.

Investment focus

Health Care, Biotechnology, Medical
Series A, Series B, Series C
Ireland, United States, France

Portfolio highlights

MMI — The future of Microsurgery: microinstruments that expand the possibilities of surgical interventions. Wristed robotic microinstruments for unprecedented results in microsurgery.
Vivasure Medical — Medical device company developing a closure device for vascular access procedures.
Ermium Therapeutics — Ermium Therapeutics is a biotech company developing innovative therapies for auto-immune diseases, based on a breakthrough discovery showing that CXCR4 is a master regulator of inflammation.

Kernel Capital is the independent manager of The Bank of Ireland Kernel Capital Venture Funds, one of the largest and most active sources of equity finance on the island of Ireland. Kernel leverage their extensive network to enable their portfolio companies recruit the highest caliber people, to break into new international markets and to generaterevenues of scale. It is the only investment firm with venture capital Funds dedicated to both jurisdictions on the Island. Kernel have raised over €210M from investors which including their strategic partner Bank of Ireland, Invest NI, Enterprise Ireland, Galway University Foundation, The University of Limerick Foundation, The New York State Common Retirement Fund and undisclosed Family Offices. Consistently delivering strong financial returns for their investors Kernel have led more than 20 substantial trade sales to NASDAQ, NYSE, and LSE listed corporations.

Investment focus

Software, Information Technology, Health Care
Funding Round, Seed, Series A
Ireland, United Kingdom, France

Portfolio highlights

Pretto — Pretto is the only truly transparent online real estate price comparator.Pretto accompanies you until the signing of your loan, free of charge and without commitment.
Pilot Photonics — Welcome to Pilot Photonics, a laser product development company in Dublin, Ireland. We provide optical frequency combs and tunable lasers.
Causeway Sensors — The Affinity, is a compact, bench-top Biosensor providing accurate real-time analysis at an accessible price. The Affinity biosensor and accompanying Access Chip incorporate the latest advancements in Nanotechnology, providing the biochemistry researcher the perfect platform to explore the complex world of biomolecular interactions.

Business Venture Partners was founded in 2004 as a corporate finance adviser for SME/owner managed businesses. The investment team is comprised of Elliott Griffin, Ronan Smith, Edel Coen and Mark Ruane and the team skills combine deep industry knowledge with experience in venture investing, corporate finance and international expansion. Theteam works on behalf of its clients buying and selling companies, raising finances, working with start-ups and advising on strategic growth, business succession and owner exits.Since 2007, BVP has successfully raised and managed 10 Simple Green BES and EII Funds. They have invested, on behalf of their investors, in some of Ireland’s most innovative companies such as Celtic Bioenergy, EFT Controls, and UrbanVolt. Our investment strategy is to spread investments over project finance and a portfolio of high potential companies. Their philosophy is to work hard with each investment to deliver valuable support for the company promoters and build shareholder value for their investors.In 2016 BVP launched The 10th BVP Green EII Fund. The fund provides eligible investors with the opportunity to avail of up to 40% income tax relief and provides the investor access to a portfolio of cleantech companies and renewable energy projects. The 11th Green Fund will be launched in Q4 2017.

Investment focus

Health Care, Information Technology, Software
Seed, Funding Round, Series A
Ireland, Luxembourg, The Netherlands

Portfolio highlights

OOHPod — Self service parcel lockers for personal and business customers. Choose from a range of plans to suit you. Pay As You Go, Monthly and Premium Subscriptions available. Find your nearest OOHPod parcel locker and start using your out of home flexible address today.
Positive Carbon — Positive Carbon provides an innovative solution for businesses to track, manage, and reduce food waste. With real-time analytics, CO2 calculation, and a comprehensive learning platform, we help you save costs and achieve sustainability goals. Request a demo today to start making a positive environmental impact.
X-BOLT Orthapaedics — X-Bolt Trauma Solutions for osteoporotic bone fixation. FDA 510(k) approved. Clinical studies include the WHITE One (n=100) and WHITE Four (n=1,140) randomized control trials.

NDRC builds high-impact new ventures. By providing the people, time, space and investment needed at the earliest stages of dedicated commercialisation work, NDRC is creating companies worthy of commercial investment and with the ability to scale. The NDRC team has the breadth of knowledge and expertise in technology and markets. NDRC worksside-by-side with researchers, entrepreneurs and venture teams to turn great ideas into successful new ventures.By the end of 2014, NDRC’s portfolio of startup ventures had secured a cumulative €88m in follow-on investment from commercial investors, with a combined market capitalisation of approx. €220m.

Investment focus

Software, Information Technology, E-Commerce
Seed, Pre-Seed, Convertible Note
Ireland, United States, United Kingdom

Portfolio highlights

Hiiker — Find 1000s of the best backpacking and hiking adventures, with reviews, photos, and great places to stay.
Legitify — Legitify is an AI powered solution using audio-video authentication that allows customers to notarize documents online remotely from anywhere, without the hassle of visiting a notary public in person.
Dataships — Dataships uses top level data privacy software to help your brand, no matter your location.

Seroba is a leading European life sciences venture capital firm focused on value creation through backing winning biotech innovations.

Investment focus

Health Care, Biotechnology, Medical
Series A, Series B, Funding Round
Ireland, United States, United Kingdom

Portfolio highlights

Shorla Pharma — Shorla Pharma is an Irish specialty pharmaceutical company. It is growing portfolio brings accessible, affordable and life-saving treatments to patients, delivering a major contribution to patient care and providing a significant clinical impact.
Storm Therapeutics — Targeting pathways that modify RNA to deliver novel cancer therapeutics.
Artica Therapeutics — Artica Therapeutics specializes in biotechnological research and development for medical devices, pharmaceutical processes, and food.

Enterprise Equity (or EEVC) is an excellent for providing capital to early stage and expanding business throughout Ireland.

Investment focus

Software, Information Technology, Medical Device
Funding Round, Seed, Series B
Ireland, United States, United Kingdom

Portfolio highlights

Phorest — Join 8000+ spas, barbers, hair, beauty and nail salon owners using the #1 management, scheduling, POS and appointment booking system. Try Phorest now!
SurgaColl — SurgaColl Technologies is a medical device company developing novel tissue regeneration products for the surgical treatment of diseases of the bone, cartilage and other human tissue. Based on technology developed at the Tissue Engineering Research Group (TERG) of the Royal College of Surgeons in Ireland (RCSI), headed by Professor Fergal O’Brien,the company aims to become a leader in the field of regenerative medical devices.
Metabolomic Diagnostics — Metabolomic Diagnostics is a deep-tech company specialized in the development of novel biomarker based diagnostic solutions for complex diseases. The company has developed an effective pipeline to firstly identify diagnostic biomarker panels and then translate these panels into clinical assays ready for application in the clinical laboratory.Thispipeline combines the biomarker multiplexing capabilities of Mass Spectrometry, a powerful analytical technology, with the company’s own informatics and statistics solutions to deliver diagnostic innovation. This is reflected in Metabolomic Diagnostics’ strong and versatile IP portfolio of technical innovations and biomarkers.Our VisionMetabolomic Diagnostics’ primary vision is to develop a portfolio of diagnostic solutions which can determine, early in a woman’s pregnancy,her risk of developing major complications much later in her pregnancy and thus enabling personalized care, adapted to each woman’s individual needs. Pregnancy complications like preeclampsia, gestational diabetes, preterm birth, and in-uterine growth restriction, all have the potential to severely impact on the well-being of mother and child.The company’s innovative diagnostic solutions will assist clinicians in re-imagining how these conditions are managed: our novel risk assessment tools are specifically developed in conjunction with prenatal care providers to ensure they make a difference that really matters. This in turn will enable clinicians to improve pregnancy outcomes globally.Our solutions will empower pregnant women: accurate pregnancy risk information will allow a pregnant woman, in partnership with her care provider, to determine what prenatal care is best for her pregnancy.

Medtech Syndicate Nominee

Investment focus

Medical, Health Care, Medical Device
Seed, Series A, Funding Round
Ireland

Portfolio highlights

Kite Medical — Kite medical has developed a novel device for detecting Kidney Reflux in children with Urinary Tract Infections. The non-invasive diagnostic solution for kidney reflux removes the need for complicated procedures and a hospital visit. Kidney reflux is the most common urological disorder in childhood, affecting up to three per cent of young children.It is most prevalent from six months to five years of age. The condition may resolve as the child gets older, but left undiagnosed and untreated it can lead to permanent kidney damage and ultimately to kidney failure.
Signum Surgical — Founded in 2014 by Eoin Bambury and Moshe Zilversmit, Signum Surgical is a medtech platform striving to develop technology that could cure perianal fistula. Bambury and Zilversmit, who met on the BioInnovate Ireland programme at NUI Galway, recognised a lack of innovation surrounding the treatment of perianal fistulas (small tunnels that developbetween the end of the bowel and the skin near the anus). The device developed by Signum Surgical is implanted post-surgery to prevent reinfection and to allow a faster healing process.

We work with leading corporations, startups, universities, and growers to solve the biggest challenges facing the agtech and foodtech industries.

Investment focus

AgTech, Agriculture, Farming
Pre-Seed, Seed, Funding Round
United States, Canada, Ireland

Portfolio highlights

Mi Terro — We are an advanced material company that engineers upcycled agricultural waste into sustainable and affordable plastic-alternative and paperless biomaterials for food, fashion and packaging industries. Our proprietary technology can potentially apply to any agricultural waste, from plants to dairy.
Continuum Ag — The mission of the Billion Bushel Challenge is to build awareness, foster creativity, and enable collaboration between farmers and biofuel manufacturers.
Cynomys — Soluzioni IOT di monitoraggio ambientale per allevamenti e aziende

Early stage VC investments and funding for start-ups / founders in Ireland.

Investment focus

Software, Information Technology, Health Care
Funding Round, Seed, Series A
Ireland, United States, United Kingdom

Portfolio highlights

Kayna — Kayna is an insurance distribution company that collaborates with vertical SaaS platforms and utilises data to offer insurance services.
Offr — Offr is the new way to buy and sell property, quickly and transparently.
Tailr — Redefining production for the clothing industry.

Cantor Fitzgerald is a global financial services firm that specializes in equities, investment banking, and real estate, fixed income and currencies, prime services, and, affiliates. The firm is known for developing advanced technologies to expand market access, and help clients achieve their most important financial and strategic objectives. Thiscommitment to client-centered innovation has led to enduring relationships with many of the world’s most demanding institutional investors and corporations. The company was founded in 1945 and is headquartered in New York.

Investment focus

Biotechnology, Health Care, Medical
Post-IPO Equity, Series B, Series A
United States, Canada, Ireland

Portfolio highlights

Wejo — We unlock limitless possibilities with connected vehicle data
Satellogic — Making Earth Observation imagery accessible and affordable to solve the world's most pressing problems
REIGO Investments — Reigo Investments is a technology company reshaping the real estate investment space. Focusing on the senior hard money lending US market, the company employs data science to improve performance, reduce defaults, and reduce underwriting time dramatically.

Glanzmann Enterprises

Investment focus

Medical, Health Care, Medical Device
Series A, Funding Round
Ireland

Portfolio highlights

Signum Surgical — Founded in 2014 by Eoin Bambury and Moshe Zilversmit, Signum Surgical is a medtech platform striving to develop technology that could cure perianal fistula. Bambury and Zilversmit, who met on the BioInnovate Ireland programme at NUI Galway, recognised a lack of innovation surrounding the treatment of perianal fistulas (small tunnels that developbetween the end of the bowel and the skin near the anus). The device developed by Signum Surgical is implanted post-surgery to prevent reinfection and to allow a faster healing process.

Boole

Investment focus

Medical Device, Health Care, Medical
Seed, Funding Round
Ireland

Portfolio highlights

Incereb — Lifelines Neuro offers exceptional infant EEG electrodes with Incereb. Learn more about this wonderful device for neonates in the NICU.
ProVerum Medical — ProVerum Medical is an early stage medical device startup for the treatment of Benign Prostatic Hyperplasia (BPH).

We work with leading corporations, startups, universities, and growers to solve the biggest challenges facing the agtech and foodtech industries.

Investment focus

AgTech, Agriculture, Farming
Pre-Seed, Seed, Funding Round
United States, Canada, Ireland

Portfolio highlights

FarmWise — FarmWise provides technology-based services that allow farmers to streamline farm operations and increase food production efficiency.
Napigen — We are the genome editing company specialized for mitochondrial engineering. We address unmet needs of future food supplies by creating hybrid crop plants to boost their yields to an unprecedented level. The company’s technology creates robust male sterile lines that are ideal over conventional lines because of their stability and elitebackgrounds. This allows the production of non-GM hybrid seeds in crop plants that are currently mostly non-hybrid such as wheat. Our technology solution is expected to fulfill the highest level of public acceptance and aspiration.
Iamus Technologies — Iamus Technologies Limited is an Artificial Intelligence & Robotics company based in Ireland that has developed poultry specific robotic technology that empowers poultry farmers to make better and safer production decisions. Over the last 2 years we have been working globally with poultry processors in identifying KPIs that our robots cancontinuously gather on the ground in poultry sheds and feedback instantly to both producer and the relevant personnel back at the processing plant. Results to date are impressive with automatic and accurate data recovery from the birds on every part of the floor and analysis with real-time intervention now possible. These factors are key in addressing the growing demands of modern, intensive broiler production with the Iamus robot & platform meeting these requirements.

Oyster Capital Partners, an Irish private equity firm, specializes in the energy technology, IT, and healthcare sectors.

Investment focus

Software, Medical Device, Enterprise Software
Series A, Funding Round, Seed
Ireland, United Kingdom, United States

Portfolio highlights

Inclusio — The inclusio diversity and inclusion platform is designed to measure and positively shift the culture of your organisation. Contact us for more information.
Ooodles — The service platform to get premium tech products for you, your business and your employees
&Open — For businesses that gift to give back, share joy, or show they care. All you need is an email.

Partisan Management Group is a highly successful, early stage venture capital investor in medical device companies.

Investment focus

Medical, Health Care, Biotechnology
Funding Round, Series A, Series B
United States, Ireland

Portfolio highlights

TriSalus Life Sciences — Surefire Medical, based in Westminster, Colorado, was founded in 2009 to develop a novel infusion system for the interventional radiology market. The Surefire's Infusion System is designed to precisely deliver embolic agents through the sophisticated expandable tip portion of its catheter. Because of this differentiated expandable tip, whichcollapses in forwarding flow to maintain blood flow and dynamically expands to the vessel wall in reverse flow to minimize reflux, Surefire's Infusion System is designed to substantially reduce damage to healthy tissue.
Enable Injections — Enable Injections designs, manufactures, and sells wearable delivery devices for injectable drugs. The Enable Injections products can deliver drugs directly from standard vials supplied by all pharmaceutical companies, can reconstitute powdered drugs into liquids as a part of the injection procedure, can inject very viscous drugs, and can inject upto 20 ml. Such products are called bolus injection systems. No other existing drug delivery device can accomplish all of these tasks. Approximately 900 new drugs are being developed that may require bolus injection technology like that being developed by Enable Injections. The total market is expected to reach $8 billion within ten years. Partisan principals have supplied 10% of the seed capital to Enable Injections. It also delivers a controlled flow of up to 50 ml of a biologic through an automatically inserted needle. Enable Injections also offers a version of the drug delivery platform that may connect to smartphones via Bluetooth. It also utilizes any standard container closure system, including syringes or vials; automatically warms and can automatically mix lyophilized solutions.Enable Injections was founded in 2010 and is headquartered in Cincinnati, Ohio, USA.
Ponce De Leon Pharmaceuticals — Ponce De Leon Pharmaceuticals is a privately financed development stage company, committed to the extension of human health span, endeavoring to offer more healthy years of living. In conjunction with the Buck Institute for Research on Aging, the Company has developed a formulation comprised of GRAS (Generally Regarded As Safe) components. Thisformulation has been shown to radically increase mean lifespan in the invertebrate model (C. Elegan), well beyond any previously published data on drugs or compounds. Testing has now begun at the Buck Institute in the mammalian model (mouse), and the Company hopes to have a patent pending product available to the public at the conclusion of those studies, or in about three years.

EIT Health is a network of best-in-class health innovators backed by the EU. We deliver solutions to enable European citizens to live longer, healthier lives.

Investment focus

Health Care, Medical Device, Medical
Grant, Pre-Seed, Seed
United Kingdom, Spain, Ireland

Portfolio highlights

Ochre Bio — Ochre Bio is developing therapies for the biggest liver health challenges.
Trak — Do you know TRAK's tele rehabilitation software? Get more clinical performance and grow your physical therapy business, request a trial!
Nanordica Medical — Nanordica Medical develops novel nanoparticle-based antibacterial wound care products.

Life Sciences Fund Amsterdam is an independent venture capital fund aiming to capitalize on new technological developments in the life sciences sector. It provides investment capital to fund high tech entrepreneurial activity in the Amsterdam Metropolitan Area in general and at the academic medical centres in particular. The fund is a specialistt fund, targeting companies that are developing commercially promising products and technologies in life sciences, including: pharmaceuticals, biotechnology, medical devices and other high technology opportunities that offer venture capital returns. The Fund focuses on seed and early stage companies, but also on pre-seed commercially viable academic projects.The close collaboration between the fund, the technology transfer offices of the Life Sciences Centre Amsterdam and the Amsterdam Biomed Cluster, enables the fund to facilitate the transfer of technology to the private sector and to provide emerging technology companies and university researchers with vital seed funding and specialized financial and technical assistance. The fund started in 2007 and is now fully invested.

Investment focus

Medical Device, Medical, Communities
Funding Round, Private Equity
Ireland, The Netherlands

Portfolio highlights

Sigmascreening — At Sigmascreening, an Amsterdam based medical device company, they focus on the development of new products in the area of breast cancer screening. Sigmascreening is established as a spin-off company from the Academic Medical Center Amsterdam (AMC Amsterdam). They have several products under development, which are all aimed at improving digitalmammography, the â€œgolden standardâ€ in breast cancer screening.
Neurent Medical — Neurent Medical is dedicated to developing highly innovative non-surgical interventions that treat chronic inflammatory Sino-Nasal diseases.

Discover start-up investing made simple. Access VC-led rounds, build your portfolio, and unlock growth at Ascentifi

Investment focus

Medical Device, Medical, Hospital
Series A, Funding Round
Ireland

Portfolio highlights

CroíValve — CroíValve is a developed a safe, effective, easy to use, percutaneous solution for treating all patients with severe Tricuspid Regurgitation
Bluedrop Medical — Evidence shows regular inspection of the feet can greatly reduce the risk of developing a diabetic foot ulcer (DFU).
X-BOLT Orthapaedics — X-Bolt Trauma Solutions for osteoporotic bone fixation. FDA 510(k) approved. Clinical studies include the WHITE One (n=100) and WHITE Four (n=1,140) randomized control trials.

Chip Hance

Investment focus

Medical, Health Care, Medical Device
Series A, Funding Round
Ireland

Portfolio highlights

Signum Surgical — Founded in 2014 by Eoin Bambury and Moshe Zilversmit, Signum Surgical is a medtech platform striving to develop technology that could cure perianal fistula. Bambury and Zilversmit, who met on the BioInnovate Ireland programme at NUI Galway, recognised a lack of innovation surrounding the treatment of perianal fistulas (small tunnels that developbetween the end of the bowel and the skin near the anus). The device developed by Signum Surgical is implanted post-surgery to prevent reinfection and to allow a faster healing process.

Norgine Ventures was started in 2012 to diversify Norgine’s activities and foster innovation in the healthcare sector. Norgine Ventures provides debt and debt-like financing to innovative, fast-growing companies in the fields of healthcare and life sciences, in Europe and the US. Norgine Ventures is backed by Norgine, a fully integrated, private,European healthcare company with over 110 years of experience in the pharma space.Norgine Ventures has full access to Norgine’s technical capabilities for evaluating investment opportunities, although the business is aimed at achieving a financial return rather than funding opportunities of strategic interest to Norgine.To date, Norgine Ventures has invested in a number of businesses, including specialty pharma, diagnostic and medical device companies, at various stages of their life cycle, both in Europe and in the US.

Investment focus

Health Care, Medical Device, Biotechnology
Funding Round, Debt Financing, Series A
France, United Kingdom, United States

Portfolio highlights

ImaginAb — ImaginAb is a biotechnology company focused on developing a new class of highly targeted diagnostic imaging agents based on engineered antibody fragments. ImaginAb's platform technology enables the rapid engineering of antibodies into fragments that retain the parental antibody but are immunologically passive and kinetically-optimized forclinical imaging. This combination of superior specificity and kinetics enables ImaginAb to generate agents that can address the unmet needs in diagnosis and patient selection for therapeutics.
PathoQuest — PathoQuest provides biosafety assays based on next-generation sequencing (NGS) for biologics quality testing. GMP biotesting for biopharmaceuticals. Learn more.
Impress — Impress – is European leading digital orthodontic DSO of new generationWe have a defensible model with the personal touch of an in-house orthodontist, true clinical expertise, and engaging directly with consumersImpress was founded in 2019 in Barcelona with the idea of combining the best of orthodontic tradition with the most innovativetechnology in the sector. From the very beginning the vision of the Impress founders was to introduce a different business model with a strong focus on medical experience and digitalization. The company is transforming the oral healthcare industry by developing its own chain of orthodontic clinics, which are characterized by their disruptive design and modern patient experience. The founders decided to build a medical company with the personal touch of in-house orthodontists, face-to-face care, and unique clinical expertise, where the proper implementation of business processes and digitalization are at the core.In less than 2 years, Impress has managed to position itself as the European leader in the orthodontic sector, has treated more than 22.000 smiles and already has a presence in more than 80 European cities. Its innovation and quality have earned it recognition from Sifted as one of the fastest growing HealthTech companies in Europe in 2020.

EarlyBird is a postal snacking service that delivers healthy snacks to its users’ doorstep. It provides its users with TasteBox, 5 healthy snacks and 2 unique teas, to help them through the working week. Its TasteBox also contains music and art from up and coming artists. EarlyBird was launched in 2014 and is based in London, England.

Investment focus

Financial Services, FinTech, Health Care
Seed, Series A, Pre-Seed
Germany, Ireland, Romania

Portfolio highlights

Sikoia — Streamline your decision-making with centralized customer data, comprehensive case management, and automated risk evaluation without complicated integrations.
Noscendo — Noscendo operates as a diagnostics company dedicated to the identification and assessment of bloodstream-associated pathogens and other infections.
Goodlegal — Goodlegal is the One-Stop-Shop for all your Legal needs. Get an out-of-the-box Legal Infrastructure Platform to handle all your problems.

Silicon Valley Bank is the financial partner of the innovation economy; helping individuals and investors in the innovation ecosystem achieve extraordinary outcomes.

Investment focus

Software, Health Care, Biotechnology
Debt Financing, Series B, Series A
United States, United Kingdom, Canada

Portfolio highlights

Carputty — Carputty is a superior way to finance a car. Buying new, used, or refinancing? Carputty's flexible line of credit simplifies the process. Get started now!
Coast — Coast is the simple, all-in-one fleet and fuel card that helps businesses easily pay for and track vehicle expenses. It's quick to set up, easy-to-use, and full of rewards.
HawkEye 360 — HawkEye 360 is a space-based RF data analytics company with one-of-a-kind solutions to better spectrum mapping and monitoring on land & water

Nadav Ben-Chanoch - Partner @ Pareto Holdings

Investment focus

Software, Information Technology, Health Care
Seed, Pre-Seed, Funding Round
United States, United Kingdom, France

Portfolio highlights

Swaap — We build the market-neutral AMM protocol.
micro1 — We help companies hire and manage the best software engineers easily.
Skedway — Every work experience should be great! Skedway is the complete platform to optimize the hybrid work experience.

Eoghan Quigley

Investment focus

Medical, Biopharma, Health Care
Seed
Ireland

Portfolio highlights

Beyondbmi — Beyondbmi is an expert led medical approach to weight loss. We provide a convenient and scientific telehealth program designed to help your reach your health goals.

DHKN has professionals in Audit, Accountancy, Corporate Finance, Tax Consultancy & Compliance, Outsourced Services and Corporate Governance & Compliance firm all under one roof in Galway.

Investment focus

Medical, Health Care, Medical Device
Funding Round
Ireland

Portfolio highlights

Versono Medical — Versono Medical is an early stage Irish MedTech company located in Galway. Our focus is on a new Medical Technology for Endovascular Surgery.

John Purdy

Investment focus

Software, FinTech, Medical
Seed, Funding Round
Ireland

Portfolio highlights

dimply — The experience & engagement platform for financial enterprises.
Beyondbmi — Beyondbmi is an expert led medical approach to weight loss. We provide a convenient and scientific telehealth program designed to help your reach your health goals.
FlowForma — Unlock competitive advantage with FlowForma, the #1 no code digital process automation software & business process management tool. Get a free trial now!

Cliff Emmons is the Chief Executive Officer of Oxys.

Investment focus

Medical, Health Care, Medical Device
Seed
Ireland

Portfolio highlights

Gasgon Medical — Medical device start-up | Improving healthcare with advanced IV technology | Infused With Confidence | Cork, Ireland.

HBM-MedFocus

Investment focus

Health Care, Biotechnology, Medical Device
Series A, Series B
Ireland, United States

Portfolio highlights

Perfuze — Perfuze was founded in 2018 by Wayne Allen and Liam Mullins. Perfuze is located within Galway City in the West of Ireland. The founders have over 30 years combined medtech experience within start-up and large corporations.Perfuze is developing innovative medical technology to treat acute ischemic stroke.Perfuze is developing innovative cathetertechnology to treat acute ischemic stroke. Their technology is intended to provide superior clinical outcomes in shorter procedural times; resulting in safe, cost-effective therapy. Perfuze was founded in 2018 by Wayne Allen and Liam Mullins. The founders have over 30 years combined medtech experience within start-up and large corporations. Perfuze is currently located in the Business Innovation Centre on the campus of the National University of Ireland, Galway, and is in the process of relocating to the IDA Business Park in Dangan, Galway.
Viseon — Viseon is a privately held medical device company committed to developing proprietary technology for use in Minimally Invasive Spine Surgery (MISS) procedures. Viseon has progressed rapidly over the past 6-months, having developed a unique array of devices to improve the procedural and clinical outcomes of many minimally invasive spine surgeryprocedures. In addition to rapid product development of its initial products, Viseon has assembled a world-class Scientific Advisory Board of leading MISS physicians, amassed 13 patents to solidify its intellectual property platform, and completed a series of pre-clinical studies supporting initial human-use, scheduled to begin soon.Viseon was founded in early 2017 as a spin-out from Rebound Therapeutics Corporation.

Moffett Investment Holdings is an investment firm

Investment focus

Medical, Health Care, Biotechnology
Series A, Series B
Ireland

Portfolio highlights

Neuromod Devices — Neuromod is a medical device company formed to advance the science of bi-modal neuromodulation.We are committed to delivering treatments that significantly reduce the suffering of underserved patient populations who live with chronic and debilitating conditions globally. Our goal is to design products that empower patients to take control oftheir own treatment, delivering targeted therapies that integrate seamlessly into a modern lifestyle.Neuromod has developed and patented a bi-modal neuromodulation technology that it is evaluating for neurological disorders including chronic tinnitus, a condition affecting 10% of the adult population and commonly known as 'ringing in the ears'.

BGF invests in hundreds of businesses from an evergreen balance sheet. But we offer more than just growth capital. Find out what makes us different.

Investment focus

Software, Information Technology, Manufacturing
Funding Round, Series A, Private Equity
United Kingdom, Ireland, United States

Portfolio highlights

Purple — Increase revenues & reduce costs with our Indoor Location Services platform that includes Guest WiFi, Digital Wayfinding & Asset Tracking solutions
Victorian Sliders — We are Victorian Sliders, the largest manufacturer of vertical sliding windows in Europe and exclusive providers of ECOSlide sash windows.
Operational Solutions — At OSL, we produce market-leading counter drone solutions to create safer spaces across a range of complex sites and environments.

Bpifrance provides financial solutions for companies that are booting up the listing on the stock exchange and credit equity. It includes OSEO, CDC Entreprises, FSI, and FSI Regions to offer in your area of financial solutions at every stage of the life of your business.Bpifrance was founded in 2012 and is based in Maisons-alfort, Ile-de-France,France.

Investment focus

Software, Information Technology, Health Care
Funding Round, Seed, Series A
France, United States, Switzerland

Portfolio highlights

HawkCell — A plug-and-play solution turning human MRI into the first animal-dedicated imaging enhanced with AI algorithms. A unique MRI solution.
Unseenlabs — Unseenlabs designs and develops a spectrum surveillance payload which is designed to detect and track non-cooperative vessels wherever they happen to be in the world.
Docent — Docent is the first AI-powered mobile application to offer a fully-personalized experience for discovering, accessing and collecting contemporary masterpieces.

Conor Sheahan is the Founder and CEO of CKS Finance. He previously worked at Ocado Information Technology Limited as a Non-Executive Director. Conor Sheahan attended the Institute of Chartered Accountants in Ireland.

Investment focus

Medical, Biopharma, Health Care
Seed
Ireland

Portfolio highlights

Beyondbmi — Beyondbmi is an expert led medical approach to weight loss. We provide a convenient and scientific telehealth program designed to help your reach your health goals.

Keiretsu Forum is a community of private equity investors, business leaders and entrepreneurs with a network of over 50 global chapters and more than 2,500 investor members.

Investment focus

Health Care, Software, Biotechnology
Series A, Seed, Funding Round
United States, Spain, Canada

Portfolio highlights

iQure Pharma — iQure Pharma preclinical and clinical drug development
Levered Learning — Levered Learning is a classroom-tested and teacher-designed instructional system providing 3rd-5th grade mathematical learning. The company was founded in 2017 by Mitch Slater and is headquartered in Soquel, California, United States.
Vartega — Vartega is a technology development company specializing in the carbon fiber-reinforced plastic recycling process. We have developed alternative technology, processes, and equipment to provide low-cost carbon fiber for use in mass market applications.

European Investment Bank (EIB) provides lending, borrowing, and treasury services primarily in the European Union.The company offers project loans for the public and private sectors; loans to banks and other intermediaries; structured finance products; guarantees and securitization instruments for senior and subordinated debts; project bonds;equity and fund investment products such as infrastructure equity and debt funds, and environmental funds; and venture capital funds and security packages for funds.The company also offers microfinance; risk sharing finance for research, development, and innovation projects; finance and technical expertise for sustainable energy projects; infrastructure project advisory services; support for urban development projects; guarantees for transport infrastructure; and funding for public-private partnerships and small- and medium-sized enterprises.EIB serves the transportation, global loans, energy, industry, health, education, water, sewerage, infrastructure, services, telecommunications, agriculture, and fisheries sectors.European Investment Bank was founded in 1958 and is based in Luxembourg.

Investment focus

Biotechnology, Health Care, Software
Debt Financing, Post-IPO Debt, Funding Round
France, Germany, The Netherlands

Portfolio highlights

Eldrive — The largest charging point operator in Eastern Europe | Our network is expanding rapidly yet our focus is fixed on renewables, for a greener future. We provide AC & DC charging across Bulgaria, Romania and Lithuania.
ABN AMRO Bank — Als bank leggen wij de focus op inclusiviteit, duurzaamheid, sociaal ondernemen, innovatie, dagelijkse bankzaken en meer.
Enel Green Power — Enel Green Power is the company that deals with renewable energy from every perspective: from direct sales through PPA, to commitment at the forefront with its plants worldwide.

Declan Magee

Investment focus

B2B, CRM, SaaS
Seed, Funding Round
Ireland

Portfolio highlights

Beyondbmi — Beyondbmi is an expert led medical approach to weight loss. We provide a convenient and scientific telehealth program designed to help your reach your health goals.
SalesOptimize — Sales/Marketing professionals love our Market Intelligence & B2B Sales Lead Platform with 120M+ B2B companies and 400M+ contacts. Join Today!

Street Capital Financial Corporation is a Canadian wholesale lending company. As a wholesale lender, Street Capital doesnâ€™t have an expensive branch network and as such can pass those savings to the consumer. Street Capital prides itself on offering consumers competitive products and interest rates with an exceptional level of service.Havingapproved lender status with Canada Mortgage and Housing Corporation (CMHC) Street Capital is able to offer a broad spectrum of residential mortgage financing products to the consumer. Also, since weâ€™re primarily focused on the mortgage broker origination channel, youâ€™re assured that your mortgage will fit your needs comfortably.By continually working to develop innovative lending solutions and working in partnership with your local mortgage brokers, Street Capital is proud to help more Canadians realize their dreams of home ownership and enhancement.

Investment focus

Medical, Automotive, Biotechnology
Seed, Funding Round
Ireland, United States

Portfolio highlights

Biosensia — Biosensia is a Point-of-Care in-vitro diagnostics company that has a novel point-of-care platform, RapiPlex, available for licensing. RapiPlex combines highly innovative technologies to produce a practical, rapid, multiplexing POC in-vitro diagnostics (IVD) platform, enabling access to a broad range of diagnostic applications. Its componentchip and cartridge system are compatible with a variety of common biological sample types, including whole blood, serum, saliva, urine and nasal/genital swabs.
Drive Time Metrics — Drive Time Metrics is developing innovative new revenue streams from connected car data, and helping automotive OEMs monetize their connected vehicle platforms.

EQT life science develops innovative medicines, devices, and tools to address the single important thing that matters to the preservation of health. The organization believes that such opportunities add value to all stakeholders.

Investment focus

Biotechnology, Health Care, Therapeutics
Series A, Series B, Series C
United States, The Netherlands, Switzerland

Portfolio highlights

VarmX — VarmX is a pharmaceutical spin-off from the Leiden University Medical Center. The mission of VarmX is to develop and manufacture therapeutic proteins to instantaneously restore blood clotting in bleeding patients. The lead product in the pipeline of VarmX is PseudoXa. PseudoXa is a modified recombinant human coagulation factor X which is capable ofimmediately restoring blood clotting in the presence of direct factor Xa anticoagulants (DOACS) such as rivaroxaban, apixaban, and edoxaban.These factor Xa coagulants are taken by millions of patients world-wide for the prevention and treatment of thrombosis and stroke, but as a side effect severe bleeding often occurs. PseudoXa is capable of stopping and preventing such bleedings thus making the usage of DOACS much safer.
Xeltis — Xeltis is pioneering a restorative approach in cardiovascular therapy.
AgomAb Therapeutics — AgomAb is developing molecular therapies for the regeneration of damaged tissues. Their unique agonistic monoclonal antibody molecules (“agomAbs”) stimulate molecular and cellular repair mechanisms that have the potential to restore organ function in patients with fibrotic, inflammatory, autoimmune and degenerative diseases.

VentureWave Capital is an actively managed private equity group that invests in and builds great companies.

Investment focus

Health Care, Apps, Business Intelligence
Funding Round, Series A
Ireland, United Kingdom

Portfolio highlights

Xocean — Using unmanned surface vessels (USVs), XOCEAN offers turnkey data collection services to Surveyors, Companies and Agencies.
Medihive — Our software and clinical solutions remove friction from patient pathways across healthcare, insurance, medtech and many more industries. Book a call today!
Funderbeam — Funderbeam is a funding and trading platform that connects companies and investors to buy and sell equity stakes. The platform allows the founders to gain exposure, legal support, a funding manager, or an investor network. It also allows the investors to take control of their investments and trade anytime they want.The company was founded in 2013as a global data platform for startup companies.

Malin Corporation plc (“Malin”) is an Irish incorporated public limited company whose head office is in Dublin, Ireland with subsidiary offices in New Haven, Connecticut and Research Triangle, North Carolina, USA.Malin’s purpose is to create shareholder value through the selective long-term application of capital and operational expertise toprivate, pre-IPO, pre-trade sale operating businesses in dynamic and fast growing segments of the life sciences industry. Through its operational involvement, Malin works with its investee companies to enable them to reach the full potential of their value proposition and to achieve commercial success.

Investment focus

Biotechnology, Health Care, Biopharma
Funding Round, Series B, Series C
United States, United Kingdom, Ireland

Portfolio highlights

CG Oncology — CG Oncology is an oncolytic immunotherapy company that is intensely focused on developing bladder saving therapeutics for patients with bladder cancer.
Poseida Therapeutics — Poseida Therapeutics is a clinical-stage biopharmaceutical company developing cell and gene therapies with the capacity to cure cancers and genetic diseases.
Xenex — Xenex is offering an effective approach to reducing the incidence of healthcare-associated infections.The Xenex mission is to save lives and reduce suffering by destroying deadly microorganisms that can cause hospital-acquired infections (HAIs). Xenex’s Pulsed Xenon Full Spectrum™ UV Disinfection Solution reduces the bacterial load oftenassociated with an increased risk for HAIs. Since its commercial launch in June 2010, Xenex devices are now included in infection control protocols in almost three hundred hospitals throughout the U.S.Xenex was founded in 2009 and headquartered in San Antonio, Texas.

HealthCap, a life science investor and company creator. Our motivation is to find innovative ideas and invest that could impact healthcare and society.

Investment focus

Biotechnology, Health Care, Medical
Series B, Series A, Funding Round
United States, Sweden, France

Portfolio highlights

ADCendo — ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs. We focus on antibody-drug conjugates (ADCs) directed at novel targets, that have been found to be overexpressed by several cancer forms, that are all characterized by a significant unmet need for novel treatment.
Vicore Pharma — Vicore Pharma is a pharmaceutical company dedicated to developing innovative medicines for severe lung disorders. It develops drugs that act through the AT2 receptor. The company’s drug candidate C21 aims to improve the treatment of idiopathic pulmonary fibrosis, a rare disease for which C21 has been granted orphan drug designation both in the EUand the US. In addition, C21 is explored pre-clinically in a number of rare diseases where the AT2 receptor plays an important role. The company is based in Astra Zeneca’s Bioventurehub in Mölndal.
Rampart Bioscience — Rampart Bioscience develops gene medicines to provide long-lasting treatments for a wide range of diseases. It also offers proprietary development and delivery platforms, which together, create optimized therapeutics in a revocable, non-viral format. It also assists patients with genetically driven diseases by integrating capabilities from avariety of key scientific disciplines including gene delivery, protein sciences, and clinical translation.

Invest Northern Ireland is Northern Ireland's economic development agency. Their overall goal is to help create wealth for the benefit of the whole community by strengthening the economy and helping it grow.

Investment focus

Health Care, Biotechnology, Medical
Funding Round, Grant, Seed
United Kingdom, United States, Ireland

Portfolio highlights

TruCorp — TruCorp: Your source for lifelike Medical Training Equipment. Explore our intubation manikins & airway trainers. Request a free demo today!
Signum Surgical — Founded in 2014 by Eoin Bambury and Moshe Zilversmit, Signum Surgical is a medtech platform striving to develop technology that could cure perianal fistula. Bambury and Zilversmit, who met on the BioInnovate Ireland programme at NUI Galway, recognised a lack of innovation surrounding the treatment of perianal fistulas (small tunnels that developbetween the end of the bowel and the skin near the anus). The device developed by Signum Surgical is implanted post-surgery to prevent reinfection and to allow a faster healing process.
CV6 Therapeutics — CV6 Therapeutics is a drug development company focused on the discovery, development and commercialization of novel therapies for the treatment of human diseases.

Investors by industry

Media (entertainment)

EdTech

Consumer

Climate